Featured conditions Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Featured conditions
The research of Stephen M. Ansell, M.D., Ph.D., is focused on understanding the biology of B-cell malignancies (including Hodgkin's lymphoma Waldenstrom's macroglobulinemia and non-Hodgkin's lymphoma) and to explore the role of the tumor microenvironment in supporting cancer cell growth and survival. The goal of his program is to translate this knowledge into new treatment approaches for patients.
Dr. Ansell's research has contributed to the use of immune checkpoint therapy in lymphomas. He led the clinical trial that resulted in the approval of nivolumab (Opdivo) for Hodgkin's lymphoma.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.